Repligen
RGEN
#1865
Rank
A$16.26 B
Marketcap
A$254.40
Share price
5.56%
Change (1 day)
10.86%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): A-$0.27

According to Repligen 's latest financial reports the company's current EPS (TTM) is A-$0.30. In 2025 the company made an earnings per share (EPS) of A$1.29 an increase over its 2024 EPS that were of A-$0.76.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.27-121.18%
2025A$1.29-270.59%
2024A-$0.76-168%
2023A$1.11-77.68%
2022A$4.9943.59%
2021A$3.48105.26%
2020A$1.69153.33%
2019A$0.6718.42%
2018A$0.56-47.95%
2017A$1.08108.57%
2016A$0.5220.69%
2015A$0.4316%
2014A$0.37-48.98%
2013A$0.736.52%
2012A$0.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.06-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$28.22-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$12.97-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.72-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A-$0.56 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A-$2.26 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$10.36-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$1.74-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.13-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$1.52-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA